Trial intelligence / Profile preview

Carbetocin IV Bolus vs Short Infusion in C-Section

NCT02221531Phase 4Completed

Sponsor
University Hospital Basel
Start
Aug 2014
Primary completion
Nov 2015
Modality
Peptides
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by University Hospital Basel. Primary endpoint: Maximal uterine tone. Started Aug 2014; status: completed.

02

Drugs

carbetocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT02221531.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02221531.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call